Northwestern Mutual Wealth Management Co. Purchases 600 Shares of Exact Sciences Corporation (EXAS)

Northwestern Mutual Wealth Management Co. lifted its position in shares of Exact Sciences Corporation (NASDAQ:EXAS) by 17.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,072 shares of the medical research company’s stock after buying an additional 600 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Exact Sciences Corporation were worth $144,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Fortaleza Asset Management Inc. purchased a new stake in shares of Exact Sciences Corporation during the 2nd quarter worth $106,000. Financial Architects Inc lifted its stake in shares of Exact Sciences Corporation by 90.0% during the 2nd quarter. Financial Architects Inc now owns 4,295 shares of the medical research company’s stock worth $152,000 after purchasing an additional 2,035 shares during the last quarter. Johnson Financial Group Inc. lifted its stake in shares of Exact Sciences Corporation by 25.9% during the 2nd quarter. Johnson Financial Group Inc. now owns 4,862 shares of the medical research company’s stock worth $172,000 after purchasing an additional 1,000 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Exact Sciences Corporation by 66.2% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,052 shares of the medical research company’s stock worth $179,000 after purchasing an additional 2,013 shares during the last quarter. Finally, Botty Investors LLC purchased a new stake in shares of Exact Sciences Corporation during the 1st quarter worth $200,000. 85.22% of the stock is currently owned by institutional investors and hedge funds.

A number of equities research analysts recently weighed in on the company. Canaccord Genuity restated a “buy” rating and set a $45.00 price objective on shares of Exact Sciences Corporation in a research note on Thursday, September 7th. BidaskClub upgraded Exact Sciences Corporation from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 25th. Leerink Swann set a $45.00 price objective on Exact Sciences Corporation and gave the stock a “buy” rating in a research note on Thursday, August 24th. Zacks Investment Research cut Exact Sciences Corporation from a “buy” rating to a “hold” rating in a research note on Friday, August 4th. Finally, Vetr cut Exact Sciences Corporation from a “buy” rating to a “hold” rating and set a $38.66 price objective for the company. in a research note on Thursday, August 3rd. Six investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $40.98.

In other news, SVP D Scott Coward sold 1,987 shares of the company’s stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $35.21, for a total transaction of $69,962.27. Following the completion of the transaction, the senior vice president now directly owns 57,603 shares of the company’s stock, valued at approximately $2,028,201.63. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Graham Peter Lidgard sold 45,775 shares of the company’s stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $41.49, for a total value of $1,899,204.75. Following the transaction, the insider now directly owns 288,952 shares of the company’s stock, valued at $11,988,618.48. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 129,291 shares of company stock valued at $5,288,181. Insiders own 4.00% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This report was originally posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://www.chaffeybreeze.com/2017/09/21/northwestern-mutual-wealth-management-co-purchases-600-shares-of-exact-sciences-corporation-exas.html.

Shares of Exact Sciences Corporation (EXAS) opened at 43.40 on Thursday. The firm has a 50-day moving average price of $40.21 and a 200-day moving average price of $32.94. Exact Sciences Corporation has a 1-year low of $13.05 and a 1-year high of $43.50. The stock’s market capitalization is $5.17 billion.

Exact Sciences Corporation (NASDAQ:EXAS) last released its quarterly earnings data on Tuesday, July 25th. The medical research company reported ($0.27) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.37) by $0.10. The business had revenue of $57.65 million during the quarter, compared to analysts’ expectations of $47.73 million. Exact Sciences Corporation had a negative return on equity of 36.36% and a negative net margin of 83.08%. On average, equities research analysts forecast that Exact Sciences Corporation will post ($1.18) earnings per share for the current year.

Exact Sciences Corporation Profile

Exact Sciences Corporation is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer. Its Cologuard test is a stool-based deoxyribonucleic acid (sDNA) screening test, which utilizes a multi-target approach to detect deoxyribonucleic acid (DNA) and hemoglobin biomarkers associated with colorectal cancer and pre-cancer.

Want to see what other hedge funds are holding EXAS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exact Sciences Corporation (NASDAQ:EXAS).

Institutional Ownership by Quarter for Exact Sciences Corporation (NASDAQ:EXAS)

Receive News & Ratings for Exact Sciences Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exact Sciences Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply